NIMI
STJ

Natixis Investment Managers International’s St Jude Medical STJ Stock Holding History

Natixis Investment Managers International’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,198
Closed -$321K – 439
2015
Q4 		$321K Buy
+5,198
New +$328K 0.04% 229

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Natixis Investment Managers International's STJ Position: Q1 2016 in Review

Natixis Investment Managers International sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 5,198 shares — an estimated $321K sold.

Natixis Investment Managers International first reported a position in STJ in Q4 2015 and held it in 1 quarter. The position peaked at $321K in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Natixis Investment Managers International reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Natixis Investment Managers International sold 5,198 St Jude Medical shares in Q1 2016, an estimated $321K.
  • Natixis Investment Managers International first reported a position in St Jude Medical in Q4 2015 and held it in 1 quarter.
  • Natixis Investment Managers International's St Jude Medical position peaked at $321K in Q4 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Natixis Investment Managers International's 13F filing for Q1 2016, filed 16 May 2016.